241 related articles for article (PubMed ID: 22089721)
1. Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Ovbiagele B; Diener HC; Yusuf S; Martin RH; Cotton D; Vinisko R; Donnan GA; Bath PM;
JAMA; 2011 Nov; 306(19):2137-44. PubMed ID: 22089721
[TBL] [Abstract][Full Text] [Related]
2. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW;
N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638
[TBL] [Abstract][Full Text] [Related]
4. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
[TBL] [Abstract][Full Text] [Related]
5. Low-normal systolic blood pressure and secondary stroke risk.
Ovbiagele B
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):633-8. PubMed ID: 22244715
[TBL] [Abstract][Full Text] [Related]
6. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial.
Estol CJ; Bath PM; Gorelick PB; Cotton D; Martin RH;
Int J Stroke; 2014 Oct; 9 Suppl A100():43-7. PubMed ID: 24636673
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial.
de Havenon A; Johnston SC; Easton JD; Kim AS; Sheth KN; Lansberg M; Tirschwell D; Mistry E; Yaghi S
JAMA Netw Open; 2021 Jun; 4(6):e2112551. PubMed ID: 34086033
[TBL] [Abstract][Full Text] [Related]
8. The PRoFESS trial: future impact on secondary stroke prevention.
Diener HC
Expert Rev Neurother; 2007 Sep; 7(9):1085-91. PubMed ID: 17868007
[TBL] [Abstract][Full Text] [Related]
9. [PRoFESS study presented. Change in secondary prevention].
MMW Fortschr Med; 2003 May; 145 Suppl 2():96-7. PubMed ID: 14579494
[No Abstract] [Full Text] [Related]
10. Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Weber R; Weimar C; Wanke I; Möller-Hartmann C; Gizewski ER; Blatchford J; Hermansson K; Demchuk AM; Forsting M; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
Stroke; 2012 Feb; 43(2):350-5. PubMed ID: 22267825
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
12. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.
Odden MC; McClure LA; Sawaya BP; White CL; Peralta CA; Field TS; Hart RG; Benavente OR; Pergola PE
Hypertension; 2016 Jan; 67(1):63-9. PubMed ID: 26553236
[TBL] [Abstract][Full Text] [Related]
13. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease.
Verdecchia P; Reboldi G; Angeli F; Trimarco B; Mancia G; Pogue J; Gao P; Sleight P; Teo K; Yusuf S
Hypertension; 2015 Jan; 65(1):108-14. PubMed ID: 25331850
[TBL] [Abstract][Full Text] [Related]
14. Consistency of blood pressure control after ischemic stroke: prevalence and prognosis.
Towfighi A; Markovic D; Ovbiagele B
Stroke; 2014 May; 45(5):1313-7. PubMed ID: 24676779
[TBL] [Abstract][Full Text] [Related]
15. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
Bath PM; Martin RH; Palesch Y; Cotton D; Yusuf S; Sacco R; Diener HC; Toni D; Estol C; Roberts R;
Stroke; 2009 Nov; 40(11):3541-6. PubMed ID: 19797187
[TBL] [Abstract][Full Text] [Related]
16. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial).
Fan F; Yuan Z; Qin X; Li J; Zhang Y; Li Y; Yu T; Ji M; Ge J; Zheng M; Yang X; Bao H; Cheng X; Gu D; Zhao D; Wang J; Sun N; Chen Y; Wang H; Wang X; Parati G; Hou F; Xu X; Wang X; Zhao G; Huo Y
Hypertension; 2017 Apr; 69(4):697-704. PubMed ID: 28242714
[TBL] [Abstract][Full Text] [Related]
17. Systolic blood pressure and mortality after stroke: too low, no go?
Lin MP; Ovbiagele B; Markovic D; Towfighi A
Stroke; 2015 May; 46(5):1307-13. PubMed ID: 25765723
[TBL] [Abstract][Full Text] [Related]
18. Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.
Mistry EA; Hart KW; Davis LT; Gao Y; Prestigiacomo CJ; Mittal S; Mehta T; LaFever H; Harker P; Wilson-Perez HE; Beasley KA; Krothapalli N; Lippincott E; Stefek H; Froehler M; Chitale R; Fusco M; Grossman A; Shirani P; Smith M; Jaffa MN; Yeatts SD; Albers GW; Wanderer JP; Tolles J; Lindsell CJ; Lewis RJ; Bernard GR; Khatri P
JAMA; 2023 Sep; 330(9):821-831. PubMed ID: 37668620
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan to prevent recurrent stroke and cardiovascular events.
Yusuf S; Diener HC; Sacco RL; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; VanderMaelen C; Voigt T; Weber M; Yoon BW;
N Engl J Med; 2008 Sep; 359(12):1225-37. PubMed ID: 18753639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
